Buprenorphine And Naloxone 00121-2036
Generic: Buprenorphine Hydrochloride And Naloxone Hydrochloride
Product NDC
00121-2036- Manufacturer
- Pai Holdings, Llc Dba Pharmaceutical Associates, Inc. And Dba Pai Pharma
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- September 5, 2023
- Listing Expires
- December 31, 2027
- Application
- ANDA204431
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 8 mg/1 |
| Naloxone Hydrochloride | 2 mg/1 |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]
Packaging Options(1)
30 TABLET in 1 BOTTLE, PLASTIC (0121-2036-30)
External Resources